Literature DB >> 26496249

Deletion of Rac in Mature Osteoclasts Causes Osteopetrosis, an Age-Dependent Change in Osteoclast Number, and a Reduced Number of Osteoblasts In Vivo.

Meiling Zhu1, Ben-Hua Sun1, Katarzyna Saar1, Christine Simpson1, Nancy Troiano2, Sarah L Dallas3, LeAnn M Tiede-Lewis3, Erin Nevius4, João P Pereira4, Robert S Weinstein5, Steven M Tommasini2, Karl L Insogna1.   

Abstract

Rac1 and Rac2 are thought to have important roles in osteoclasts. Therefore, mice with deletion of both Rac1 and Rac2 in mature osteoclasts (DKO) were generated by crossing Rac1(flox/flox) mice with mice expressing Cre in the cathepsin K locus and then mating these animals with Rac2(-/-) mice. DKO mice had markedly impaired tooth eruption. Bone mineral density (BMD) was increased 21% to 33% in 4- to 6-week-old DKO mice at all sites when measured by dual-energy X-ray absorptiometry (DXA) and serum cross-linked C-telopeptide (CTx) was reduced by 52%. The amount of metaphyseal trabecular bone was markedly increased in DKO mice, but the cortices were very thin. Spinal trabecular bone mass was increased. Histomorphometry revealed significant reductions in both osteoclast and osteoblast number and function in 4- to 6-week-old DKO animals. In 14- to 16-week-old animals, osteoclast number was increased, although bone density was further increased. DKO osteoclasts had severely impaired actin ring formation, an impaired ability to generate acid, and reduced resorptive activity in vitro. In addition, their life span ex vivo was reduced. DKO osteoblasts expressed normal differentiation markers except for the expression of osterix, which was reduced. The DKO osteoblasts mineralized normally in vitro, indicating that the in vivo defect in osteoblast function was not cell autonomous. Confocal imaging demonstrated focal disruption of the osteocytic dendritic network in DKO cortical bone. Despite these changes, DKO animals had a normal response to treatment with once-daily parathyroid hormone (PTH). We conclude that Rac1 and Rac2 have critical roles in skeletal metabolism.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  OSTEOCLASTS; OSTEOCYTES; RAC1; RAC2

Mesh:

Substances:

Year:  2015        PMID: 26496249      PMCID: PMC4826801          DOI: 10.1002/jbmr.2733

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  38 in total

1.  The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone.

Authors:  Eleanor Knopp; Nancy Troiano; Mary Bouxsein; Ben-Hua Sun; Karen Lostritto; Caren Gundberg; James Dziura; Karl Insogna
Journal:  Endocrinology       Date:  2004-12-23       Impact factor: 4.736

2.  Vav3 regulates osteoclast function and bone mass.

Authors:  Roberta Faccio; Steven L Teitelbaum; Keiko Fujikawa; Jean Chappel; Alberta Zallone; Victor L Tybulewicz; F Patrick Ross; Wojciech Swat
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

3.  The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts.

Authors:  Virginie Vives; Mélanie Laurin; Gaelle Cres; Pauline Larrousse; Zakia Morichaud; Danièle Noel; Jean-François Côté; Anne Blangy
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

4.  Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activity.

Authors:  Takashi Itokowa; Mei-ling Zhu; Nancy Troiano; Jessica Bian; Tustomu Kawano; Karl Insogna
Journal:  Calcif Tissue Int       Date:  2010-11-26       Impact factor: 4.333

5.  Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts.

Authors:  Hiroaki Sakai; Yan Chen; Takashi Itokawa; Kuan-Ping Yu; Mei-Ling Zhu; Karl Insogna
Journal:  Bone       Date:  2006-09-01       Impact factor: 4.398

6.  Targeted overexpression of the two colony-stimulating factor-1 isoforms in osteoblasts differentially affects bone loss in ovariectomized mice.

Authors:  Gang-Qing Yao; Jian-Jun Wu; Shira Ovadia; Nancy Troiano; Ben Hua Sun; Karl Insogna
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-13       Impact factor: 4.310

7.  Increased connective tissue extracellular matrix in the op/op model of osteopetrosis.

Authors:  Zaher A Radi; Roberto E Guzman; Rosonald R Bell
Journal:  Pathobiology       Date:  2009-06-29       Impact factor: 4.342

8.  Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis.

Authors:  Yongqiang Wang; Dina Lebowitz; Chunxiang Sun; Herman Thang; Marc D Grynpas; Michael Glogauer
Journal:  J Bone Miner Res       Date:  2008-02       Impact factor: 6.741

9.  The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice.

Authors:  Tsutomu Kawano; Nancy Troiano; Douglas J Adams; Jian Jun Wu; Ben-hua Sun; Karl Insogna
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

Review 10.  Sclerostin: current knowledge and future perspectives.

Authors:  M J C Moester; S E Papapoulos; C W G M Löwik; R L van Bezooijen
Journal:  Calcif Tissue Int       Date:  2010-05-15       Impact factor: 4.333

View more
  9 in total

1.  Spontaneous mutation of Dock7 results in lower trabecular bone mass and impaired periosteal expansion in aged female Misty mice.

Authors:  Phuong T Le; Kathleen A Bishop; David E Maridas; Katherine J Motyl; Daniel J Brooks; Kenichi Nagano; Roland Baron; Mary L Bouxsein; Clifford J Rosen
Journal:  Bone       Date:  2017-08-15       Impact factor: 4.398

2.  The contribution of cross-talk between the cell-surface proteins CD36 and CD47-TSP-1 in osteoclast formation and function.

Authors:  Srinivas V Koduru; Ben-Hua Sun; Joanne M Walker; Meiling Zhu; Christine Simpson; Madhav Dhodapkar; Karl L Insogna
Journal:  J Biol Chem       Date:  2018-08-06       Impact factor: 5.157

3.  An Unanticipated Role for Sphingosine Kinase-2 in Bone and in the Anabolic Effect of Parathyroid Hormone.

Authors:  Joanne M Walker; Gang-Qing Yao; Edwin Siu; Meiling Zhu; Ben-Hua Sun; Christine Simpson; Karl L Insogna
Journal:  Endocrinology       Date:  2021-05-01       Impact factor: 4.736

Review 4.  Role and mechanism of action of leucine-rich repeat kinase 1 in bone.

Authors:  Weirong R Xing; Helen Goodluck; Canjun Zeng; Subburaman Mohan
Journal:  Bone Res       Date:  2017-03-14       Impact factor: 13.567

5.  LRRK1 regulation of actin assembly in osteoclasts involves serine 5 phosphorylation of L-plastin.

Authors:  Mingjue Si; Helen Goodluck; Canjun Zeng; Songqin Pan; Elizabeth M Todd; Sharon Celeste Morley; Xuezhong Qin; Subburaman Mohan; Weirong Xing
Journal:  J Cell Biochem       Date:  2018-08-22       Impact factor: 4.429

6.  Protocadherin-7 Regulates Osteoclast Differentiation through Intracellular SET-Binding Domain-Mediated RhoA and Rac1 Activation.

Authors:  Hyunsoo Kim; Noriko Takegahara; Yongwon Choi
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

Review 7.  Mouse Cre Models for the Study of Bone Diseases.

Authors:  Sarah L Dallas; Yixia Xie; Lora A Shiflett; Yasuyoshi Ueki
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

8.  Leucine-rich repeat kinase-1 regulates osteoclast function by modulating RAC1/Cdc42 Small GTPase phosphorylation and activation.

Authors:  Canjun Zeng; Helen Goodluck; Xuezhong Qin; Bo Liu; Subburaman Mohan; Weirong Xing
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-09-06       Impact factor: 4.310

9.  3D Bioprinted Osteogenic Tissue Models for In Vitro Drug Screening.

Authors:  Erick Breathwaite; Jessica Weaver; Justin Odanga; Myra Dela Pena-Ponce; Jung Bok Lee
Journal:  Molecules       Date:  2020-07-29       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.